Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Protoveratrine A hydrochloride
RN: 58445-86-6
UNII: YGM9ZJF06C
InChIKey: CWXLRJWGWPIDOZ-XGTFUUGSSA-N

Classification Code

  • Drug / Therapeutic Agent

Molecular Formula

  • C41-H63-N-O14.Cl-H

Molecular Weight

  • 830.4026
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Protoveratrine A hydrochloride

Synonyms

  • Protoveratrine A hydrochloride
  • Protoveratrine hydrochloride
  • UNII-YGM9ZJF06C

Systematic Name

  • Cevane-3-beta,4-beta,6-alpha,7-alpha,14,15-alpha,16-beta,20-octol, 4,9-epoxy-, 6,7-diacetate, 3-((+)-2-hydroxy-2-methylbutyrate) 15-((-)-2-methylbutyrate), hydrochloride

Registry Numbers

CAS Registry Number

  • 58445-86-6

FDA UNII

  • YGM9ZJF06C

System Generated Number

  • 0058445866

Molecular Formulas

Molecular Formula

  • C41-H63-N-O14.Cl-H

Molecular Formula Fragments

  • C41-H63-N-O14
  • Cl-H
  • COMPONENT

Structure Descriptors

InChI

1S/C41H63NO14.ClH/c1-10-20(4)34(46)55-33-28(45)27-23(18-42-17-19(3)12-13-25(42)38(27,9)49)24-16-39-32(40(24,33)50)30(53-22(6)44)29(52-21(5)43)31-36(39,7)15-14-26(41(31,51)56-39)54-35(47)37(8,48)11-2;/h19-20,23-33,45,48-51H,10-18H2,1-9H3;1H/t19-,20+,23-,24-,25-,26-,27+,28+,29-,30+,31-,32+,33-,36-,37-,38+,39+,40-,41+;/m0./s1

InChIKey

CWXLRJWGWPIDOZ-XGTFUUGSSA-N

Smiles

CC[C@@H](C)C(=O)O[C@H]1[C@@H]([C@H]2[C@@H](CN3C[C@H](CC[C@H]3[C@@]2(C)O)C)[C@H]4[C@@]1([C@@H]5[C@@H]([C@@H]([C@H]6[C@]7([C@]5(C4)O[C@@]6([C@H](CC7)OC(=O)[C@](C)(CC)O)O)C)OC(=O)C)OC(=O)C)O)O.Cl

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 48ug/kg (0.048mg/kg) PERIPHERAL NERVE AND SENSATION: FLACCID PARALYSIS WITHOUT ANESTHESIA (USUALLY NEUROMUSCULAR BLOCKAGE)

LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Journal of Pharmacology and Experimental Therapeutics. Vol. 82, Pg. 167, 1944.